Second cancers in patients with brain tumours-impact of treatment

By Salminen E.   Pukkala E.   Teppo L.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 102-105

Elsevier

Access to resources Recommend Favorite

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours

By Poulsen Hans Skovgaard   Grunnet Kirsten   Sorensen Morten   Olsen Preben   Hasselbalch Benedikte   Nelausen Knud   Kosteljanetz Michael   Lassen Ulrik  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 52-58

Informa Healthcare

Access to resources Recommend Favorite

Biopolymer-mediated suramin chemotherapy in the treatment of experimental brain tumours

By Bellinzona Mattia   Roser Florian   Matthies Cordula   Samii Madjid   Saini Marco  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 259-263

Informa Healthcare

Access to resources Recommend Favorite

Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours - a study by the Societe Francaise d'Oncologie Pediatrique

By Doz F.   Neuenschwander S.   Bouffet E.   Gentet J.C.   Schneider P.   Kalifa C.   Mechinaud F.   Chastagner P.   De Lumley L.   Sariban E.   Plantaz D.   Mosseri V.   Bours D.   Alapetite C.   Zucker J.M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 815-819

Elsevier

Access to resources Recommend Favorite

Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma - a new era in the treatment of malignant brain tumours?

By Henriksson Roger   Bergstrom Per   Johansson Mikael   Sandstrom Maria  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 6-8

Informa Healthcare

Access to resources Recommend Favorite